Global Diabetes Drugs Market Growth 2023-2029

Global Diabetes Drugs Market Growth 2023-2029

Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

LPI (LP Information)' newest research report, the “Diabetes Drugs Industry Forecast” looks at past sales and reviews total world Diabetes Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetes Drugs sales for 2023 through 2029. With Diabetes Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Drugs industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Diabetes Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Drugs.

The global Diabetes Drugs market size is projected to grow from US$ 52360 million in 2022 to US$ 77210 million in 2029; it is expected to grow at a CAGR of 77210 from 2023 to 2029.

Global Diabetes Drugs key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 80%.

North America is the largest market, with a share over 50%, followed by Europe and China, both have a share over 30%.

In terms of product, Insulin is the largest segment, with a share over 45%. And in terms of application, the largest application is Type 1 Diabetes, followed by Type 2.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Insulin

DPP-4

GLP-1

SGLT-2

Segmentation by application

Type 1 Diabetes

Type 2 Diabetes

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Sanofi

AstraZeneca

Bayer

Biocon

Boehringer Ingelheim

Dongbao Pharmaceutical

Eli Lilly

Ganlee

Ginwa

Guangzhou Baiyun Mountain

Hisun Pharmacy

Hua Dong

Huadong Medicine

Jumpcan Pharmacy

KELUN

Merck & Co.

MSD

North China Pharmaceutical Group Corporation

Novartis

Novo Nordisk

Sanofi

SHIJIAZHUANG YILING PHARMACEUTICAL

Takeda

Taloph

Tianan Pharmaceutical

Tonghua DongBao

Wanbang Biopharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Diabetes Drugs market?

What factors are driving Diabetes Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Diabetes Drugs market opportunities vary by end market size?

How does Diabetes Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.